Benzinga.com

JMP: Time To Buy Axovant Sciences, Probability For RVT-101 Success 'High'

In a report published Wednesday, JMP Securities analyst Jason N. Butler initiated coverage of Axovant Sciences Ltd AXON with a Market Outperform rating and a price target of $36. Axovant is a ...
Yahoo Finance

JMP Views Positive Phase 3 Data Equivalent To 'Schizophrenia Blockbuster' For This Stock

JMP Securities raised the price target on Karuna Therapeutics Inc (NASDAQ: KRTX) from $175 to $190 with a Market Outperform rating. The analysts note Karuna as the top pick ahead of imminent Phase 3 ...
Investing

Citizens JMP reiterates Market Outperform rating on Acadia stock ahead of trial results

Investing.com - Citizens JMP has reiterated its Market Outperform rating and $38.00 price target on Acadia Pharmaceuticals (NASDAQ:ACAD), currently trading at $24.76, as the company prepares to report ...
Degital PR Platform

「JMP（R） 15」、「JMP（R） Pro 15」、および「JMP（R） Live」の提供 ...

～よりいっそうデータの探索や理解が容易に～ アナリティクスのリーディング・カンパニーであるSAS Institute Japan株式会社（本社：東京都港区、代表取締役社長：堀田 徹哉、以下 SAS）のJMPジャパン事業部は、探索的データ分析ソフトウェア「JMP（ジャンプ ...